Valuation TAUNS Laboratories,Inc.
Stocks
197A
JP3452250008
Medical Equipment, Supplies & Distribution
|
Delayed
Japan Exchange
05:25:30 06/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 473.00 JPY | -3.07% |
|
-3.46% | -6.88% |
Company Valuation: TAUNS Laboratories,Inc.
Data adjusted to current consolidation scope
| Fiscal Period: June | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Market Cap 1 | 41,000 | 55,086 | 52,125 | - | - |
| Change | - | 34.36% | -5.38% | - | - |
| Enterprise Value (EV) 1 | 41,114 | 60,244 | 60,119 | 62,794 | 62,840 |
| Change | - | 46.53% | -0.21% | 4.45% | 0.07% |
| P/E | 7.1x | 8.67x | 9.81x | 16.2x | 14.3x |
| PBR | 3x | 3.15x | 2.65x | 2.66x | 2.59x |
| PEG | - | 1.16x | -0.5x | -0.4x | 1.1x |
| Capitalization / Revenue | 2.22x | 2.96x | 3.53x | 3.24x | 2.97x |
| EV / Revenue | 2.23x | 3.23x | 4.07x | 3.9x | 3.58x |
| EV / EBITDA | 4.72x | 6.71x | 11.9x | 10.2x | 9.37x |
| EV / EBIT | 5.12x | 7.29x | 15.6x | 14.2x | 12.6x |
| EV / FCF | - | - | - | - | - |
| FCF Yield | - | - | - | - | - |
| Dividend per Share 2 | 21.75 | 28 | 35.28 | 28.5 | 29 |
| Rate of return | 5.3% | 5.2% | 7.23% | 5.84% | 5.94% |
| EPS 2 | 57.74 | 62.07 | 49.72 | 30.1 | 34.15 |
| Distribution rate | 37.7% | 45.1% | 71% | 94.7% | 84.9% |
| Net sales 1 | 18,435 | 18,628 | 14,756 | 16,097 | 17,565 |
| EBITDA 1 | 8,706 | 8,980 | 5,325 | 6,147 | 6,708 |
| EBIT 1 | 8,030 | 8,265 | 3,846 | 4,418 | 4,979 |
| Net income 1 | 5,774 | 6,315 | 5,201 | 3,211 | 3,643 |
| Net Debt 1 | 114.1 | 5,157 | 7,994 | 10,670 | 10,715 |
| Reference price 2 | 410.00 | 538.00 | 488.00 | 488.00 | 488.00 |
| Nbr of stocks (in thousands) | 100,000 | 102,391 | 106,813 | - | - |
| Announcement Date | 13/08/24 | 13/08/25 | 13/08/26 | - | - |
1JPY in Million2JPY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 9.65x | 4.02x | 11.73x | 7.35% | 330M | |
| 38.21x | 4.47x | 16.8x | 2.25% | 197B | |
| 29.15x | 5.18x | 17.71x | 1.07% | 128B | |
| 22.72x | 3.84x | 13.74x | 2.7% | 128B | |
| 33.19x | 3.18x | 12.84x | 2.15% | 99B | |
| 18.78x | 0.22x | 13.95x | 0.67% | 64.82B | |
| 42.64x | 3.78x | 12.86x | 2% | 58.17B | |
| 47.01x | 11.64x | 32.68x | -.--% | 52.84B | |
| 29.36x | 7.27x | 18.57x | 1.38% | 50.69B | |
| 45.89x | 3.62x | 13.43x | 0.48% | 37.23B | |
| Average | 31.66x | 4.72x | 16.43x | 2% | 81.57B | |
| Weighted average by Cap. | 32.88x | 4.54x | 16.46x | 1.7% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 197A Stock
- Valuation TAUNS Laboratories,Inc.
Select your edition
All financial news and data tailored to specific country editions
